PubMed

Chemotherapy for older patients with newly diagnosed, advanced-stage, aggressive-histology non-Hodgkin lymphoma: a systematic review.

Kouroukis CT, Browman GP, Esmail R, Meyer RM.

Ann Intern Med. 2002 Jan 15;136(2):144-52. Review.PMID: 11790067 [PubMed - indexed for MEDLINE]Related articles

Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.

Hagemeister FB.

Cancer Chemother Pharmacol. 2002 May;49 Suppl 1:S13-20. Epub 2002 Apr 12. Review.PMID: 12042984 [PubMed - indexed for MEDLINE]Related articles

Influence of amifostine on toxicity of CHOP in elderly patients with aggressive non-Hodgkin's lymphoma--a phase II study.

Späth-Schwalbe E, Lange C, Genvresse I, Krüger L, Eucker J, Schweigert M, Sezer O, Budach V, Possinger K.

Anticancer Drugs. 2002 Apr;13(4):395-403.PMID: 11984085 [PubMed - indexed for MEDLINE]Related articles

Randomized phase II study of biweekly CHOP and dose-escalated CHOP with prophylactic use of lenograstim (glycosylated G-CSF) in aggressive non-Hodgkin's lymphoma: Japan Clinical Oncology Group Study 9505.

Itoh K, Ohtsu T, Fukuda H, Sasaki Y, Ogura M, Morishima Y, Chou T, Aikawa K, Uike N, Mizorogi F, Ohno T, Ikeda S, Sai T, Taniwaki M, Kawano F, Niimi M, Hotta T, Shimoyama M, Tobinai K; Members of the lymphoma study group of the Japan Clinical Oncology Group (JCOG).

Ann Oncol. 2002 Sep;13(9):1347-55.PMID: 12196359 [PubMed - indexed for MEDLINE]Related articlesFree article

Rituximab-CHOP-ESHAP vs CHOP-ESHAP-high-dose therapy vs conventional CHOP chemotherapy in high-intermediate and high-risk aggressive non-Hodgkin's lymphoma.

Intragumtornchai T, Bunworasate U, Nakorn TN, Rojnuckarin P.

Leuk Lymphoma. 2006 Jul;47(7):1306-14.PMID: 16923561 [PubMed - indexed for MEDLINE]Related articles

Biweekly CHOP or THP-COP regimens in the treatment of newly diagnosed aggressive non-Hodgkin's lymphoma. A comparison of doxorubicin and pirarubicin: a randomized phase II study.

Tsurumi H, Yamada T, Sawada M, Kasahara S, Kanemura N, Kojima Y, Fukuno K, Hara T, Saio M, Takahashi T, Oyama M, Ozawa K, Takami T, Moriwaki H.

J Cancer Res Clin Oncol. 2004 Feb;130(2):107-13. Epub 2003 Nov 27.PMID: 14648210 [PubMed - indexed for MEDLINE]Related articles

Dose-intense chemotherapy every 2 weeks with dose-intense cyclophosphamide, doxorubicin, vincristine, and prednisone may improve survival in intermediate- and high-grade lymphoma: a phase II study of the Southwest Oncology Group (SWOG 9349).

Blayney DW, LeBlanc ML, Grogan T, Gaynor ER, Chapman RA, Spiridonidis CH, Taylor SA, Bearman SI, Miller TP, Fisher RI; Southwest Oncology Group.

J Clin Oncol. 2003 Jul 1;21(13):2466-73.PMID: 12829664 [PubMed - indexed for MEDLINE]Related articles

A randomised multicentre trial of modified CHOP versus MCOP in patients aged 65 years and over with aggressive non-Hodgkin's lymphoma.

Bessell EM, Burton A, Haynes AP, Glaholm J, Child JA, Cullen MH, Davies JM, Smith GM, Ellis IO, Jack A, Jones EL; Central Lymphoma Group UK.

Ann Oncol. 2003 Feb;14(2):258-67.PMID: 12562653 [PubMed - indexed for MEDLINE]Related articlesFree article

First-line treatment with brief-duration chemotherapy plus rituximab in elderly patients with intermediate-grade non-Hodgkin's lymphoma: phase II trial.

Hainsworth JD, Litchy S, Lamb MR, Rodriguez GI, Scroggin C Jr, Greco FA.

Clin Lymphoma. 2003 Jun;4(1):36-42.PMID: 12837153 [PubMed - indexed for MEDLINE]Related articles

Intensive conventional chemotherapy (ACVBP regimen) compared with standard CHOP for poor-prognosis aggressive non-Hodgkin lymphoma.

Tilly H, Lepage E, Coiffier B, Blanc M, Herbrecht R, Bosly A, Attal M, Fillet G, Guettier C, Molina TJ, Gisselbrecht C, Reyes F; Groupe d'Etude des Lymphomes de l'Adulte.

Blood. 2003 Dec 15;102(13):4284-9. Epub 2003 Aug 14.PMID: 12920037 [PubMed - indexed for MEDLINE]Related articlesFree article

Effective immunochemotherapy for aggressive non-Hodgkin's lymphoma.

Coiffier B.

Semin Oncol. 2004 Feb;31(1 Suppl 2):7-11. Review.PMID: 15042528 [PubMed - indexed for MEDLINE]Related articles

A prospective study of P-IMVP-16/CBDCA: a novel salvage chemotherapy for patients with aggressive non-Hodgkin's lymphoma who had previously received CHOP therapy as first-line chemotherapy.

Sawada M, Tsurumi H, Yamada T, Hara T, Fukuno K, Goto H, Shimizu M, Kasahara S, Yoshikawa T, Kanemura N, Oyama M, Takami T, Moriwaki H.

Eur J Haematol. 2002 Jun;68(6):354-61.PMID: 12225393 [PubMed - indexed for MEDLINE]Related articles

Stage I-IIE primary non-Hodgkin's lymphoma of the testis: results of a prospective trial by the GOELAMS Study Group.

Linassier C, Desablens B, Lefrancq T, Le Prise PY, Harousseau JL, Jacob C, Gandhour C, Haillot O, Lucas V, Leloup R, Escoffre M, Colombat P, Tabuteau S; GOELAMS Study Group.

Clin Lymphoma. 2002 Dec;3(3):167-72.PMID: 12521394 [PubMed - indexed for MEDLINE]Related articles

Combined chemotherapy with carmustine, doxorubicin, etoposide, vincristine, and cyclophosphamide plus mitoxantrone, cytarabine and methotrexate with citrovorum factor for the treatment of aggressive non-Hodgkin lymphoma: a long-term follow-up study.

Rigacci L, Carrai V, Nassi L, Alterini R, Longo G, Bernardi F, Bosi A.

Cancer. 2005 Mar 1;103(5):970-7.PMID: 15666323 [PubMed - indexed for MEDLINE]Related articlesFree article

Community-based trial of R-CHOP and maintenance rituximab for intermediate- or high-grade non-Hodgkin lymphoma with first-cycle filgrastim for older patients.

Case DC Jr, Desch CE, Kalman LA, Vongkovit P, Mena RR, Fridman M, Allen B.

Clin Lymphoma Myeloma. 2007 Mar;7(5):354-60.PMID: 17562245 [PubMed - indexed for MEDLINE]Related articles

A comparison of elderly patients with aggressive histology lymphoma who were entered or not entered on to a randomized phase II trial.

Chen CI, Skingley P, Meyer RM.

Leuk Lymphoma. 2000 Jul;38(3-4):327-34.PMID: 10830739 [PubMed - indexed for MEDLINE]Related articles

Efficacy of fludarabine/mitoxantrone/dexamethasone alternating with CHOP in bulky follicular non-Hodgkin's lymphoma.

Wilder DD, Ogden JL, Jain VK.

Clin Lymphoma. 2002 Mar;2(4):229-37.PMID: 11970762 [PubMed - indexed for MEDLINE]Related articles

CHOP with high dose cyclophosphamide consolidation versus CHOP alone as initial therapy for advanced stage, indolent non-Hodgkin's lymphomas.

Pan D, Qin J, Farber C, O'Brien J, Filippa D, Portlock CS.

Leuk Lymphoma. 2003 Jun;44(6):967-71.PMID: 12854895 [PubMed - indexed for MEDLINE]Related articles

Aggressive lymphoma: improving treatment outcome with rituximab.

Coiffier B, Pfreundschuh M, Stahel R, Vose J, Zinzani PL.

Anticancer Drugs. 2002 Nov;13 Suppl 2:S43-50.PMID: 12710590 [PubMed - indexed for MEDLINE]Related articles

ACVBP versus CHOP plus radiotherapy for localized aggressive lymphoma.

Reyes F, Lepage E, Ganem G, Molina TJ, Brice P, Coiffier B, Morel P, Ferme C, Bosly A, Lederlin P, Laurent G, Tilly H; Groupe d'Etude des Lymphomes de l'Adulte (GELA).

N Engl J Med. 2005 Mar 24;352(12):1197-205.PMID: 15788496 [PubMed - indexed for MEDLINE]Related articlesFree article